Context: Corydalis yanhusuo W.T. Wang (Papaveraceae) (Rhizoma Corydalis) showed inhibitory effects on rabbit platelet aggregation induced by ADP, thrombin (THR) or arachidonic acid (AA).
Introduction
Rhizoma Corydalis (RC), the dried tubers of perennial herb Corydalis yanhusuo Y. H. Chou & Chun C. Hsu) W. T. Wang ex Z. Y. Su & C. Y. Wu (Papaveraceae) , has a wide range of pharmacological activities such as promotion of blood circulation, antioxidant, alleviating pain, inhibition proliferation of cancer cell, antiulcer, antihypertension and vasorelaxant (Leung et al. 2003; Wu et al. 2007; Gao et al. 2009; Wang et al. 2010; Qu et al. 2015) . The function of improving the blood circulation to treat thrombosis associated cardiovascular diseases of RC became increasingly attractive. And among hundreds of chemical components such as organic acids, amino acids, sugars, steroids and volatiles in RC (Zhang et al. 2008; Shi et al. 2011; Su & Guo 2011; Wang et al. 2012; Yang et al. 2014) , alkaloids are revealed to be its main chemical compounds and major pharmacologically active ingredients (Cheng et al. 2006; Wang et al. 2010; Yang et al. 2014) . For example, the previous research has reported the antiplatelet aggregation effect of the dehydrocorydaline by increasing the platelet cyclic adenosine monophosphate (cAMP) and decreasing cGMP level, as well as inhibiting the expression of the fourth factor (PF4) induced by ADP (Yang et al. 1989; Ding et al. 2007 ). In addition, the work by our group has demonstrated that RC extracts showed strong antiplatelet activity against AA, THR and ADP-induced platelets aggregation (Chen et al. 2016 ). In reality, as a therapeutic natural drug for arterial and venous thrombosis, the mechanism of RC on antiplatelet effect is still unclear.
Platelets, small subcellular fragments, have crucial roles in haemostasis and thrombosis after tissue trauma and vascular injury (Coller & Shattil 2008; Smyth et al. 2009 ). Platelet aggregation in blood vessels causes thrombosis and results in various clinical disorders. Therefore, the underlying mechanisms of platelet activation and aggregation play important roles in preventing and treating cardiovascular and thrombosis-related diseases. Platelet proteomics is an effective strategy to identify a wide range of signal cascades involved in platelet activation (Marcone et al. 2015) . Among various techniques used in platelet proteomics, gel-free and iTRAQ together with MS or LC-MS/MS, 2-DE coupled to kinds of MS were frequently applied to characterize platelets in cardiovascular diseases and in exploring effects of antiplatelet drugs (Coppinger et al. 2007; Arias-Salgado et al. 2008; Parguiña et al. 2010 Parguiña et al. , 2011 L opez-Farr e et al. 2011) . One of the application of 2-DE coupled to MS is to identify the expression of platelet proteins and suggest the possible signalling pathways after treated with traditional Chinese medicines (TCMs) and active compounds, such as Panax notoginseng (Burkill) F. H. Chen (Araliaceae) (Yao et al. 2008b) , salvianolic acids (Yao et al. 2008a ) and salvianolic acid B (Ma et al. 2011) from Salvia miltiorrhiza Bunge (Labiatae).
In the present study, a method combining two-dimensional electrophoresis (2-DE) and MALDI-TOF-MS/MS analysis was applied to separate and explore target-regulated platelet proteins, and then based on the results to suggest possible signalling pathways of antiplatelet aggregation of RC. Furthermore, the Ca 2þ , Pselectin, 5-HT and cGMP levels in platelets treated with RC were also measured to further confirm its antiplatelet mechanism.
Materials and methods

Regents and chemicals
Pentobarbital sodium, HEPES, THR, ADP, arachidonic acid (AA), ortho-phthalaldehyde, Fura-2/AM and 5-HT were from Sigma (St, Louis, MO). NH 4 HCO 3 , K 3 Fe(CN) 6 , Na 2 S 2 O 3 , acetonitrile, trifluoroacetic acid (TFA), trypsin and the protease inhibitor cocktail (P-9599) were from Sigma (Promega, Madison, WI). Immobiline Drystrips (IPG strips) (pH 4-7, 13 cm), Drystrip cover fluid, 2-D clean-up kit and IPG buffer (pH 3-10 and pH 4-7) were obtained from GE Healthcare (GE Healthcare Bio-Science, Uppsala, Sweden). N, N-methylene-bis acrylamide, acrylamide, dithiothreitol (DTT), iodoacetamide, low meltingtemperature agarose, 2-amino-2-(hydroxymethyl)-1,3-propanediol (Tris), glycine, urea, thiourea and coomassie brilliant blue G-250 were purchased from Sangon Biotech Co., Ltd. (Shanghai, China 
Preparation of RC sample
The dried RC powder (50 g) was extracted with 150 mL 90% ethanol in an ultrasonic cleanser tank for 20 min, along with reflux extraction for 1 h at 80 C, filtered and another fresh 150 mL 90% ethanol was added into the residue, repeated the reflux extraction and filtered. The filtrates were combined and dried at 45 C using a rotary evaporator and further dried in an oven at 50 C. The obtained RC 90% ethanol extract was dissolved in natural saline before incubated with washed platelets.
Preparation of rabbit washed platelet
Healthy rabbits (2-3 kg) were from animal farm in Chongqing, China. Rabbit washed platelets were used for proteomic analysis and identifying target-related proteins. All experimental procedures were approved by the Institutional Animal ethical Committee of Chongqing University and were conducted according to the Guide for Care and Use of Laboratory Animal of the National Institute of Health (Publication No. 80-23, revised 1996) .
Preparation of rabbit washed platelet was processed according to the previous report with some modifications (Xia et al. 2012 ). Blood from rabbit carotid artery was obtained in plastic tubes with ACD (0.8% aitric acid, 2.2% sodium citrate, 2.45% glucose) anticoagulant (ACD: blood ¼1:6, v/v). After centrifugation at 196 Â g for 12 min at room temperature, platelet rich plasma (PRP) was isolated and then centrifuged again at 2325 Â g for 12 min. The suspension solution was obtained as platelet poor plasma (PPP). Washed platelets were obtained by washing the bottom platelet pellet twice with washing buffer (138 mM NaCl, 12 mM NaHCO 3 , 2.7 mM KCl, 0.36 mM NaH 2 PO 4 Á2H 2 O, 5.5 mM glucose and 0.2 mM EGTA). Finally, platelets were re-suspended in Tyrode buffer (134 mM NaCl, 12 mM NaHCO 3 , 2.9 mM KCl, 0.34 mM NaH 2 PO 4 Á2H 2 O, 0.8 mM MgCl 2 Á6H 2 O, 5 mM HEPES, 5 mM glucose) with a cell density of 3 Â 10 8 cells/mL.
Protein extraction
Washed platelets were incubated with natural saline (blank control) or 50 mg/mL RC 90% alcohol extracts (RC-treated) for 15 min at 37 C. Subsequently, platelets were washed three times with PBS-glucose buffer [PBS (pH 7.4): 5% (w/v) glucose ¼1:9, isosmotic solution] and centrifuged at 3246 Â g for 10 min. The pellets were dissolved in lysis buffer containing 7 M urea, 2 M thiourea, 2% (w/v) CHAPS, 40 mM DTT and 0.02% (w/v) protease-inhibitor for 30 min on ice, then the protein solution was purified by 2-D Clean-up kit. Finally, the pellet was re-suspended in 150 lL lysis buffer [7 M urea, 2 M thiourea, 2% CHAPS, 40 mM DTT, 0.25% (v/v) pharmalyte] for 2-DE analysis.
Two-dimensional electrophoresis
Two-dimensional electrophoresis analysis was performed on a GE 2-DE system. Briefly, 150 lL protein samples were applied for isoelectric focusing (IEF) using Drystrip IPG strips (13 cm, pH 4-7). Before IEF, IPG strips were rehydrated 20 h in hydration solution [7 M urea, 2 M thiourea, 4% CHAPS, 40 mM DTT, 0.3% pharmalyte pH 4-7, 0.2% pharmalyte pH 3-10]. Then, the IPG strips were placed into Ettan IPGphor Manifold and the proteins were separated based on their pI. After IEF, the IPG strips were equilibrated and then directly transferred onto 10% SDS-PAGE gels (gel dimensions 14 Â 16 cm). Control and RCtreated platelet protein samples for three independent experiments were analyzed by 2-DE. The gels were then silver stained and the images were processed by the PDQuest (Bio-rad, Hercules, CA). The gel images from control and RC-treated group were compared and matched. Furthermore, quantitative analysis was performed using the Student's t-test between protein gels of RC-treated and control group. The differentially expressed (increased or decreased in intensity) protein spots (p < 0.05) with more than twofold between control and RC-treated group were selected and further identified by MALDI-TOF-MS/MS.
Identifications of target proteins
The differentially expressed proteins were manually selected and extracted from gels. MS analysis was performed based on the reported method . Briefly, gels were destained with 30 mM K 3 Fe(CN) 6 in 50% 100 mM Na 2 S 2 O 3 and 100 mM NH 4 HCO 3 , dried in ACN and digested with trypsin. Then, peptides were extracted by 0.1% TFA in 50% ACN, and the samples were air-dried and analyzed with an ABI 4800 MALDI-TOF/TOF Proteomics Analyzer (Applied Biosystems, Wilmington, DE). All databases were searched using Mascot search engine in the NCBInr protein sequence database restricted to Oryctolagus cuniculus. Mass tolerance for peptides is 100 ppm and mass tolerance of TOF/TOF fragments is 0.6 Da using cysteine carbamidomethylation for a fixed modification. Meanwhile, methionine oxidation was used as a variable modification. The confidence in the peptide mass fingerprinting matches (p < 0.05) was determined based on the MOWSE score.
Determination of intracellular Ca 21 levels of platelet
Intracellular Ca 2þ concentration transients were measured by Fura-2/AM fluorescence according to the previous report (Xia et al. 2012) . In brief, rabbit PRP platelet was incubated with Fura-2/AM (final concentration of 2 lM) for 45 min at 37 C. Before re-suspended at 3 Â 10 8 cells/mL with the Tyrode-Hepes, the above platelets were washed twice by washing buffer. Afterwards, platelets were incubated with various concentrations of RC (final concentrations of 0.0156-0.1563 mg/mL), and blank control PBS solution (0.01 mol/L) at 37 C for 5 min, and the Fura-2 fluorescence was monitored at an excitation wavelength of 340/380 nm and an emission wavelength of 500 nm. Finally, the fluorescence intensity after THR-induced (0.25 u/mL) platelet aggregation was measured by the same method.
Quantification of platelet P-selectin and cGMP by ELISA
Competitive enzyme-linked immunosorbent assay (ELISA) method was carried out to measure the levels of P-selectin and cGMP. Rabbit PRP platelets at a concentration of 3 Â 10 8 cells/mL were incubated with 10 lL RC extracts (final concentrations of 0.0156-1.5625 mg/mL), 0.25 u/mL THR and blank control PBS solution (0.01 mol/mL) at 37 C for 5 min, respectively, and then the RC-treated groups were incubated with 10 lL THR (0.25 u/mL) for 5 min at 37 C. Then, 13 mM EDTAÁNa 2 was added to the tubes to terminate the progress on ice. After centrifuged at 8232 Âg for 5 min, the supernatants were collected. Finally, soluble P-selectin and cGMP contents were analyzed using a microplate reader at a wavelength of 450 nm according to the manufactures' instructions, respectively.
Measurement of platelet 5-HT
Platelet 5-HT content was measured based on the previous report with minor modifications (Jin et al. 2004) . Firstly, rabbit PRP platelets were incubated with RC extracts (final concentrations of 0.3125-1.5625 mg/mL), and control PBS solution (0.01 mol/L) for 3 min at 37 C, and then immediately stimulated with agonists (THR 0.25 u/mL, AA 0.205 mmol/L and ADP 10 lmol/L). After 5 min, the reaction was stopped by adding 1% precooled EDTAÁNa 2 on ice. Supernatants were obtained by centrifugation at 6961 Â g for 10 min, 300 lL solution of each sample was used for measuring fluorescence intensity. Meanwhile, the fluorescence intensity of 0.3 mL 0.6 mg/L 5-HT standard solution was also measured. Secondly, three concentrations (0.3125, 0.7813 and 1.5625 mg/mL) of RC-treated platelet samples (respectively activated by three agonists) were mixed with TCA and Tyrode-Hepes. After centrifuged at 6961 Â g for 10 min, supernatants were incubated with OPT/HCl at 100 C for 10 min. The solution was cooled on ice for 10 min and then mixed with trichloromethane. The fluorescence intensity of solution was monitored at excitation wavelength of 340 nm and emission wavelength of 470 nm after centrifuged at 2325 Â g for 10 min.
Statistical analysis
PDQuest (Bio-rad, Hercules, CA) software was applied to process the 2-DE images, the quantitative analysis of protein spots were performed using the Student's t-test between protein gels for RCtreated and control group. All data were analyzed by origin 8.5.1, and presented as mean ± SD, p values of .05 or less were considered to be statistically significant.
Results
2-DE analysis of control and RC-treated platelets
Protein profiles of control and RC-treated platelets are shown in Figure 1 , up to 900 protein spots were monitored after each image processed by PDQuest software, and the matching rates up to 90% among three 2-DE gel maps indicate good reproducibility of three independent experiments. Twenty-six downregulated and 26 upregulated protein spots were found by comparing 2-DE gel maps of control and RC-treated groups. The differentially expressed proteins are indicated by the arrows in Figure 1 , and the enlarged spots are shown in Figure 2 . The fold differences, indicating the ratio of the protein spots' intensity values of control to RC-treated group are shown in Table 1 
Identification of the differentially expressed proteins
The protein spots ( Figure 2 ) with more than twofold differences in RC-treated and control group were identified by MALDI-TOF-MS/MS. The NCBI accession number, theoretical molecular weight, pI, protein score and coverage of each spot of 51 protein spots are shown in Table 1 . There were 12 cytoskeleton proteins, i.e., gamma non-muscle actin, lamin isoform X1 and prohibitin; 7 cell signalling proteins, such as Ras-related protein Rap-1b, annexin A4 and ADP-ribosylation factor 3; three molecular chaperone proteins, including heat shock cognate 71 kDa protein, protein disulphide isomerase-associated 3 precursor and chaperonin-containing T-complex; 6 directly related to the platelet function proteins, 16 enzymes and 7 other proteins.
Effect of RC on platelet calcium level
As shown in Figure 3 (A), the Ca 2þ contents of both resting and THR-induced platelets were affected by RC 90% alcohol extracts. From the Figure 3 (A), RC extracts with middle (0.0313 mg/mL) and high (0.1563 mg/mL) concentrations can significantly inhibit the intracellular calcium levels against the resting platelet (p < 0.001, vs. resting platelet), and the Ca 2þ concentration was decreased from 130.28 ± 5.96 to 89.59 ± 7.04 nM (resting platelet group: 130.28 ± 5.96 nM). Furthermore, compared with the THR-activated group (172.73 ± 5.07 nM), the RC-treated group has strong inhibition function on the release of Ca 2þ increased by THR. For example, RC extracts at the concentration of 0.0313 mg/mL can obviously inhibit the Ca 2þ release in THRinduced platelets and the Ca 2þ levels was decreased from 172.73 ± 5.07 to 113.56 ± 5.46 nM (p < 0.001, vs. THR-activated group).
Effects of RC extract on the platelet P-selectin and cGMP levels
As shown in Figure 3(B) , compared with the resting platelets, the content of P-selectin was obvious increased in THR-stimulated platelet (resting group: 11.12 ± 0.84 ng/3 Â 10 8 , THR-activated group: 13.48 ± 0.96 ng/3 Â 10 8 ). And RC extracts with final concentration 0.0156 mg/mL treatment were decreased the content of P-selectin to 11.64 ± 0.17 ng/3 Â 10 8 (p < 0.05, vs. THR-activated group), but the inhibition function with middle (0.1563 mg/mL) and high (1.5625 mg/mL) concentrations of RC were not obvious. On the other hand, one of the major inhibitory pathways in platelets is represented by the NO/cGMP/PKG pathway (Li et al. 2010) , and the activation of PKG and PKA depended on the availability of cGMP. In the present study, platelet cGMP levels were greatly increased after RC treatment (Figure 3(C) ) as compared to that of THR-activated platelets, Control RC-treated Figure 2 . The differentially expressed protein spots in Figure 1 . 
Effect of RC extract on the platelet 5-HT level
As an indolamine platelet agonist, platelet or extracellular 5-HT can act on the platelet serotonin receptor, 5-HT2A, and stimulates Gq-mediated PLCb activation that results in the increased (Offermanns 2006) . As shown in Figure 3(D) , the intracellular 5-HT contents in platelet activated by AA, ADP and THR can be downregulated by RC treatment, respectively. RCtreated groups had a strong inhibition effect on the THR-induced intracellular 5-HT release, and the inhibition rates of three concentrations (0.3125, 0.7813 and 1.5625 mg/mL) were 83.40, 96.80 and 96.05%, respectively. Furthermore, RC can also suppressed AA-induced platelets 5-HT release at the three concentrations with the inhibiting rates of 63.51, 60.31 and 71.54%, respectively. Relatively, RC-treatment had a mild inhibition effect on ADPinduced intracellular 5-HT release (16.41, 22.26 and 21.05%, respectively).
Discussion
According to our previous reported, RC extracts could inhibit ADP, AA and THR-induced rabbit platelets aggregation (Chen et al. 2016) . Understanding the mechanism of RC on antiplatelet aggregation would be important for RC to be developed as a natural antiplatelet drug. In the present study, platelet proteomic analysis based on 2-DE combined with MLDAI-TOF-MS/MS analysis was used to separate and identify target-related proteins in RC-treated platelets (Table 1) . Based on their biological functions, 51 identified proteins were classified into following five categories: (1) cytoskeleton structure proteins; (2) cell signalling proteins;
(3) platelet function directly related proteins; (4) molecular chaperones proteins; (5) enzymes and other proteins. Cytoskeletal and actin-associated proteins (such as profiling, lamin) were cytoskeleton proteins, which shared cruel roles in maintenance of platelet shape. The remodelling of the resting cytoskeleton and the assembly of new cytoskeleton are required when platelet shape change, this physiological process is associated with a sturdy internal cytoskeleton composed of the polymers of actin and tubulin and their associated proteins (Boyles et al. 1985; Patel-Hett et al. 2008; Michelson 2013) . After exposure of rabbit washed platelets to RC, lamin isoform X1, tropomodulin-3 and actin-related protein 3 were upregulated, which may directly result in signal transduction pathways to stimulate or regulate actin polymerization and its stability (Rohatgi et al. 1999; Schmidt & Hall 1999; .
Some cell signalling proteins have been previously reported to be associated with calcium signalling pathways, such as Annexin A4, synaptotagmin-7 and transient receptor potential cation channel subfamily M member 3. G-protein-couple receptors (GPCRs), a family of seven-transmembrane domain receptors, play a pivotal role in the transmembrane signalling process as they take part in processing and sorting of incoming signals, and are centrally involved in the second phase of platelet-dependent thrombus formation (Offermanns 2003 (Offermanns , 2006 . Meanwhile, G-protein consist of an a-subunit which binds and hydrolyzes guanosine triphosphate (GTP) as well as an band an c-subunit, and three major G-protein-mediated signalling pathways involved in platelet activation via GPCRs that are initiated by the activation of the G protein Gq, G13 and Gi. Importantly, platelet stimulated by ADP is mediated by two G protein-coupled receptor, P2Y12 and P2Y1 (P2Y1 couples to Gq, P2Y12 couples to Gitype G proteins). Interestingly, P2Y12 receptor binding Gi protein is a major mechanism responsible for the activation of phosphoinositide 3-kinase (PI3K) (Hollopeter et al. 2001; Gachet 2006) . Therefore, the downregulation of guanine nucleotide-binding protein G(i) subunit a-2 after RC-treated platelets indicated that P2Y12 receptor might be one of the direct target proteins of RC in platelet to mediate Gai signalling pathways for the inhibition of platelet aggregation. Ras-related protein Rap-1b (an abundant small GTPase), which is the predominant Rap 1 isoform and the most abundant Ras family member in platelets, has been reported to activate downstream GPCRs and upstream integrin a IIb b 3 . Predominantly, ADP stimulates Rap 1b activation mainly via a calcium-independent pathway to activate downstream Gai-coupled P2Y12 receptor, and also activates phosphoinositide 3-kinase and its lipid product phosphatidylinositol 3,4,5triphosphate (Lova et al. 2002; Crittenden et al. 2004; Chrzanowska-Wodnicka et al. 2005) . Hence, the expression of Ras-related protein Rap-1b down regulated after treated with RC is corresponded to CalDAG-GEFI (calcium-DAG-GEF/RasGRP protein family) and PI3K signalling pathways. Especially, Annexin A4 was cytosolic calcium-binding protein with four repeat domains, each containing one calcium-binding site, and interacted with lipid membranes in a calcium-dependent manner (Rescher & Gerke 2004; Arii et al. 2015) . On the other hand, different isoforms of adenylyl cyclase (AC, AC1-AC9) have wide range of physiological regulations, the enzymatic activity of ACs are responsible for the synthesis of cAMP from ATP stimulated through GPCRs (Defer et al. 2000) . It had been reported that annexin A4 was a novel regulator of adenylyl cyclase 5 (AC5), occupying critical functions associated with stimulation of the b-adrenoceptor in multiple tissues (Heinick et al. 2015) . So the downregulation of annexin A4 after RC treatment might be directly interacting with membrane-bound AC5 to regulate GPCRs signal pathways. In addition, ADP-ribosylation factor 3 (ARFs 3) was also downregulated after RC treatment. ARFs 3 is a member of ARF family with small GTPase, which are associated with vesicle formation from different intracellular site as well as in the regulation of phospholipase D activity and cytoskeleton modifications (Shome et al. 1998; Belov et al. 2005) .
Three molecular chaperone proteins (heat shock cognate 71 kDa protein, protein disulphide isomerase-associated 3 precursor and chaperonin-containing T-complex polypeptide beta subunit) were also identified and listed in Table 1 . Molecular chaperones are a group of structurally diverse proteins including heat shock proteins, t-complex polypeptide 1 (TCP-1 complex), which play a crucial role in facilitating the correct folding of protein by preventing protein aggregation or facilitating the forward folding and assembly of proteins into higher order structure (Hartl & Hayer-Hartl 2002; Young et al. 2004) . A previous report showed that Heat shock protein 70 protected the centrosome and perhaps intermediated filaments during heat shock and played cooperative roles in the formation and function of the eukaryotic cell cytoskeleton (Liang & MacRae 1997) , it is supposed that the downregulation of heat shock cognate 71 kDa protein may have similar functions with Heat shock protein 70. Protein disulphide isomerase-associated 3, a membrane of protein disulphide isomerase (PDI), was also downregulated by RC treatment. Evidence indicates that the oxidation state of labile disulphide bonds play critical roles in regulating the process of thrombus formation, and important for fibrin generation and platelet accumulation (Cho et al. 2008; Jasuja et al. 2010) .
Some of the identified proteins are directly related to platelet functions. Fibrinogen consists of three pairs of polypeptide chains (Aa, Bb and c) linked by disulphide bonds, which can bind a IIb b3 receptor resulted in platelet aggregation after platelets being activated (Mustard et al. 1978; Marguerie et al. 1980 ). Furthermore, fibrinogen binds through its c chains (i.e., fibrinogen c chain isoform X1, protein spot 47) to growth factors and coagulation factors to perform its key roles in fibrin clot formation, platelet aggregation and wound healing (Farrell 2004; Lovely et al. 2007 ). Peroxiredoxin-6, which can be downregulated in platelet treated with RC, is a family member of peroxiredoxins for antioxidant proteins related to either protection against oxidation or participation in signalling by the reduction of H 2 O 2 (Da Silva-Azevedo et al. 2009; Ambruso 2013) .
As listed in Table 1 , nearly 30% identified proteins were enzymes that catalyzed several reactions in antiplatelet signalling cascades, for example, succinyl-CoA catalyzed GAP to GTP and succinic acid. Arachidonate 12-lipoxygenase 12S-type (protein spot 38), an isoform of lipoxygenase, which showed broad substrate specificity and could directly oxygenate polyunsaturated fatty acids esterified to cholesterol in low-density lipoprotein (LDL) particle (K€ uhn et al. 1994; Brash 1999) . Arachidonic 12lipoxygenase also could catalysis AA to 12(S)-hydroxyeicosatetranoic acid (12-HETE), which can block the platelets aggregation induced by collage and arachidonate, or negative feedback to prevent excess aggregation by interfering with the liberation of arachidonic acid from membrane phospholipids (Siegel et al. 1979; Sekiya et al. 1990 ). Hence, the down-regulated expression of arachidonate 12-lipoxygenase (12S-type) in RC treated rabbit platelets may mediate arachidonic acid signalling pathway to inhibit platelet aggregation. Guanylate cyclase soluble (sGC) subunit b-1 (protein spot 29), a GTP-binding protein, which was downregulated in platelet after treated with RC, could catalyze the formation of cGMP from GTP (Tomita et al. 1997; Li et al. 2010) . Interestingly, sGC played important roles in the activation of NO/cGMP/PKG/MAPK signalling pathway for GPIb-IX-mediated platelet activation (Li et al. 2010) .
When platelets stimulated by physiological agonists, the release of granule secretions including P-selectin, 5-HT, ADP and Ca 2þ will amplify platelet activation and to recruit circulating platelet response to agonists. Among which calcium was sequentially activated integrin a IIb b3, this process is called 'inside-out signalling' (Li et al. 2010 ), in addition, numerous signalling pathways and molecules were stimulated by calcium levels, including signalling actin-myosis interaction, PKC, calmodulin, NO synthase, etc. (Hassock et al. 2002; Bergmeier & Stefanini 2009 ). During the inside-out signalling, endothelial nitric oxide synthase (eNOS) was simulated and continually activated soluble guanylyl cyclase (sGC), then catalyzed guanylic acid to cGMP. And the activated cGMP as an important secondary messenger was sequentially induced the downstream receptor PKG and PLA 2 (phospholipase) activation to amplify platelet activation signalling pathway (Li et al. 2003 (Li et al. , 2010 . In the present study, RC can decrease the levels of P-selectin, 5-HT and Ca 2þ , and increase the level of cGMP, especially RC has strong inhibition function for platelet Ca 2þ release.
In summary, RC-treated rabbit platelets could alter 51 targetregulated proteins' expression, those proteins play important roles in platelet activation, oxidation stress and cytoskeleton structure. Importantly, four proteins closely related to platelet activation, i.e., fibrinogen beta chain and serum albumin precursor, were upregulated in RC-treated platelets. Furthermore, guanine nucleotide-binding protein G(i) subunit a-2, which plays cruel role in platelet-activated signalling cascades, can be downregulated by RC extract. On the other hand, RC treatment showed obvious effect on the contents of the calcium, P-selectin, cGMP and 5-HT in AA, THR and AA-activated platelet. Based on the results of the present study and the previous reported about the signalling pathways of platelet activation, the possible signalling pathways of RC antiplatelet aggregation were summarized in Figure 4 . One of the signal cascades of RC after binding with P2Y12 receptor might mediate the Gai proteins to activate downstream AC signalling pathway, and the other was Gai-mediated PI3K signalling pathway to activate downstream proteins. Therefore, P2Y12 receptor might be one of the direct target proteins of RC in platelet and then to mediate Gai signalling pathways for the inhibition of platelet functions.
Conclusion
In the present study, platelets treated by RC was analyzed using 2-DE based comparative proteomics, and 52 proteins altered in the expression level after RC extract treatment were identified by MALDI-TOF-MS/MS. Some of the identified proteins play cruel roles in the platelet signalling cascades as shown in Figure 4 . Based on the present study, the effect of RC on platelet function might be related to its binding to P2Y12 receptor and mediated Gai signalling pathways. Furthermore, RC can decrease the levels of 5-HT, Ca 2þ and P-selectin, and increase cGMP levels in ADP, THR and AA induced platelets. Up to date, this is the first study to identify the possible target-related proteins and suggest the possible antiplatelet signalling cascades of RC by platelet proteomics. The results of present study provide evidences for further study on the antiplatelet aggregation signal pathways of active components in RC. 
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